Bill > A03283

This bill, known as the "bioterrorism prevention act," requires companies that create synthetic genes (gene synthesis providers) and those that make equipment for this purpose to follow rules set by the department of health. These rules will include procedures for identifying genetic sequences that could be dangerous, checking out potential customers, and keeping records of the genes they create or provide. The department will base these regulations on established industry practices and recommendations from groups like the international gene synthesis consortium. A "gene synthesis provider" is defined as any business that makes and gives synthetic nucleic acids (the building blocks of genes) to customers or distributors.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/A3283